Key Insights

Highlights

Success Rate

38% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

25.0%

5 terminated out of 20 trials

Success Rate

37.5%

-49.0% vs benchmark

Late-Stage Pipeline

30%

6 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results38% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (6)
P 1 (1)
P 2 (2)
P 3 (2)
P 4 (4)

Trial Status

Recruiting8
Terminated5
Completed3
Enrolling By Invitation1
Unknown1
Withdrawn1

Trial Success Rate

37.5%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT06980948Phase 1RecruitingPrimary

Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)

NCT05537935Phase 4Recruiting

Low Dose Naltrexone for Pain in Patients With HIV

NCT07468799Not ApplicableCompleted

High-Frequency rTMS Over the DLPFC for Chronic Low Back Pain

NCT05593237Not ApplicableActive Not RecruitingPrimary

Transcranial Magnetic Stimulation for Chronic Neuropathic Pain

NCT07154056Not ApplicableRecruitingPrimary

Evaluation of the Efficacy of STNS With FAST and MULTIWAVE in Patients With Refractory Chronic Neuropathic Pain

NCT07301632Phase 2RecruitingPrimary

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial

NCT06710808Not ApplicableCompleted

VIRTUAL WALKING AND TRANSCRANIAL DIRECT CURRENT STIMULATION FOR CHRONIC NEUROPATHIC PAIN DUE TO SPINAL CORD INJURY

NCT06647576Enrolling By InvitationPrimary

Exploring Neurosphere's Remote Monitoring and Virtual Clinic Features in Improve Quality of Life and Reduce Costs

NCT06741579Phase 3Recruiting

Mechanisms of Stimulation for Pain Alleviation

NCT07187219Not ApplicableRecruiting

Efficacy of Repetitive Transcranial Magnetic Stimulation Over the Primary Cortex in Patients With Neuropathic Pain and Cancer

NCT06731335Phase 2RecruitingPrimary

Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

NCT04936646Not ApplicableRecruitingPrimary

Study of RTMS Analgesic Effect in Chronic Neuropathic Pain,

NCT04287075TerminatedPrimary

Surgical Treatment of Chronic Neuropathic Pain

NCT01205516Phase 4TerminatedPrimary

Methadone in Neuropathic Pain

NCT02335489TerminatedPrimary

A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg

NCT03259451WithdrawnPrimary

Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Neuropathic Pain

NCT00214955Phase 3CompletedPrimary

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

NCT01437332Unknown

Molecular Mediators of Nerve Injury Signaling

NCT00189059Phase 4TerminatedPrimary

Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.

NCT00189072Phase 4TerminatedPrimary

Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition

Showing all 20 trials

Research Network

Activity Timeline